The Journal of Neuropsychiatry and Clinical Neurosciences
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
J Neuropsychiatry Clin Neurosci 17:324-332, August 2005
doi: 10.1176/appi.neuropsych.17.3.324
© 2005 American Neuropsychiatric Association
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
* Citation Map
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Google Scholar
Google Scholar
* Articles by Gilbert, D. L.
* Articles by Buncher, C. R.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Gilbert, D. L.
* Articles by Buncher, C. R.
Related Collections
* Other Neuropsychiatric Disorders

Special Article

Assessment of Scientific and Ethical Issues in Two Randomized Clinical Trial Designs for Patients With Tourette’s Syndrome: A Model for Studies of Multiple Neuropsychiatric Diagnoses

Donald L. Gilbert, M.D., M.S. and C. Ralph Buncher, Sc.D.

Received August 4, 2004; revised October 6, 2004; accepted October 22, 2004. From the Division of Neurology, Cincinnati Children’s Hospital Medical Center and University of Cincinnati, Cincinnati, Ohio; the Division of Biostatistics and Epidemiology, University of Cincinnati, Cincinnati, Ohio. Address correspondence to Dr. Gilbert, Cincinnati Children’s Hospital Medical Center, ML #2015, 3333 Burnet Ave., Cincinnati, OH 45229-3039; d.gilbert{at}cchmc.org (E-mail.)

Most clinical trials in Tourette’s syndrome (TS) involve fewer than 60 patients. This is partially due to difficulties recruiting patients who have multiple neuropsychiatric diagnoses. Few studies permit treatment of comorbid diagnoses or compare active treatments. As a result, standard clinical practice requires choices between multiple agents shown to be superior to placebo agents in highly selected samples but never compare the two. Clinical practice also requires use of untested medication combinations. The authors review scientific and ethical shortcomings of placebo-controlled, monotherapy trials in TS, proposing specific conditions and methods and discussing the scientific, ethical, and economic implications of an alternative design: randomized, active-comparator, rater-only blinded clinical trials.

Key Words: Randomized Controlled Clinical Trials • Tourette’s Syndrome




This article has been cited by other articles:


Home page
J Child NeurolHome page
D. Gilbert
Treatment of Children and Adolescents With Tics and Tourette Syndrome
J Child Neurol, August 1, 2006; 21(8): 690 - 700.
[Abstract] [PDF]




Get information about faster international access.

Privacy Policy

Copyright © 2005 American Neuropsychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Neuropsychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org